CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
© 2019 Wiley Periodicals, Inc. Background: Serine-arginine protein kinase (SRPK) is a regulator of alternative splicing events via phosphorylation of splicing factor proteins. Oncogenic roles of SRPK1 and SRPK2 have been reported in various types of cancer. To date, only SRPK1/2 specific inhibitors...
Saved in:
Main Authors: | Pongphol Prattapong, Chawalit Ngernsombat, Sathid Aimjongjun, Tavan Janvilisri |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/59883 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Wnt8b as an independent prognostic marker for nasopharyngeal carcinoma
by: Chawalit Ngernsombat, et al.
Published: (2022) -
Epstein-barr virus mediated signaling in nasopharyngeal carcinoma carcinogenesis
by: Timmy Richardo, et al.
Published: (2020) -
Linking aberrant splicing to cardiac aging : unravelling SRPK2
by: Meroshini, M.
Published: (2016) -
CRISPR/CAS9-MEDIATED BETA-2 MICROGLOBULIN KNOCKOUT TO MODULATE IMMUNOGENICITY
by: ZHA SHIJUN
Published: (2018) -
Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis
by: Kittiya Supradit, et al.
Published: (2022)